Skip to content

An Evidence-Based Evaluation Study on the Substitution Effect of Acupuncture for Anesthetic Drugs Based on Colonoscopy

An Evidence-Based Evaluation Study on the Substitution Effect of Acupuncture for Anesthetic Drugs Based on Colonoscopy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001270
Enrollment
Unknown
Registered
2025-06-26
Start date
2024-12-01
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Taking patients undergoing painless colonoscopy as the research subjects

Interventions

acupuncture group:The intervention protocol involves administering real acupuncture followed by real electroacupuncture, along with sham fentanyl and propofol, without the use of actual fentanyl
Sham acupuncture group:The intervention protocol involves administering sham acupuncture followed by sham electroacupuncture, along with real fentanyl and propofol, without the application of actual a

Sponsors

Tianjin Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Enrollment criteria: Patients must meet all of the following criteria to be enrolled in this study: Age 18 to 65 years regardless of gender; Patients undergoing painless colonoscopy; ASA score of I or II; BMI between 18 kg/m² and 28 kg/m²; Fully understand and voluntarily participate in the study and sign the informed consent form personally.

Exclusion criteria

Exclusion criteria: Exclusion criteria: Patients with any of the following conditions cannot be enrolled in this study: Patients scheduled for tracheal intubation (including laryngeal mask); Patients requiring complex endoscopic diagnostic or therapeutic procedures; Patients with a history of intestinal stenosis or adhesions; Patients with acute heart failure unstable angina or myocardial infarction within the past 6 months; Patients with severe respiratory disease; Patients with psychiatric disorders a history of long-term use of psychiatric medications or cognitive impairment; Patients deemed difficult to manage in terms of respiratory tract (Modified Mallampati score of IV); Patients with severe impairment of vital organs such as the liver and kidneys; Patients with a history of drug abuse drug addiction or alcoholism within the past 2 years (alcoholism defined as averaging more than 2 units of alcohol per day (1 unit = 360 mL of beer 45 mL of 40% alcohol content liquor or 150 mL of wine)); Patients who have not received regular antihypertensive treatment or have poorly controlled blood pressure (systolic blood pressure =160 mmHg or =90 mmHg and/or diastolic blood pressure =100 mmHg in the sitting position during the screening period); Patients who have taken benzodiazepines and/or opioids daily or intermittently within the past month or three months; Patients allergic to or with contraindications to opioids propofol or their components; Pregnant or lactating women; Patients (including males) planning to conceive within the next 3 months; Patients who have participated in any clinical trial within the past 3 months; Patients deemed unsuitable for this trial by the investigator.

Design outcomes

Primary

MeasureTime frame
Total dosage of propofol;

Secondary

MeasureTime frame
Evaluation of Anesthesia Safety;Quality Evaluation of Colonoscopy;Evaluation of Patient and Physician Satisfaction;The dosage of propofol per kilogram of body weight;Evaluation of Sedation Quality;Additional administration of propofol;

Countries

China

Contacts

Public ContactWangChunyan

The Department of Anesthesiology Tianjin Medical University General Hospital

0208wcy@163.com13512206486

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026